Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells: Modulation by corticosteroids and T-helper 2 cytokines

American Journal of Respiratory Cell and Molecular Biology

Volumn 21, Issue 4, 1999, Pages 528-536

  Pype, Jan L ^b   Dupont, Lieven J ^b   Menten, Patricia ^b   Van Coillie, Els ^b   Opdenakker, Ghislain ^b   Van Damme, Jo ^b   Chung, K Fan ^b   Demedts, Maurits G ^b   Verleden, Geert M ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CCL8 CHEMOKINE; CYCLOHEXIMIDE; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES;

ARTICLE; BRONCHUS; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; SMOOTH MUSCLE; TH2 CELL;

BRONCHI; CELLS, CULTURED; CHEMOKINE CCL2; CYCLOHEXIMIDE; CYTOKINES; DEXAMETHASONE; GENE EXPRESSION; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-4; MONOCYTE CHEMOATTRACTANT PROTEINS; MUSCLE, SMOOTH; RANTES; RNA, MESSENGER; TH2 CELLS;

EID: 0033210754     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.21.4.3660     Document Type: Article

References (60)

1. Thompson, A. B., D. Daughton, R. A. Robbins, M. A. Ghafouri, M. Oehlerking, and S. I. Rennard. 1989. Intraluminal airway inflammation in chronic bronchitis: characterization and correlation with clinical parameters. Am. Rev. Respir. Dis. 140:1527-1537.
2. Kuna, P., M. Lazarovich, and A. P. Kaplan. 1996. Chemokines in seasonal allergic rhinitis. J. Allergy Clin. Immunol. 97:104-112.
3. Bousquet, J., P. Chanez, J. Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, and P. Godard. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
4. Bradley, B. L., M. Azzawi, M. Jacobson, B. Assoufi, J. V. Collins, A. M. Irani, L. B. Schwartz, S. R. Durham, P. K. Jeffery, and A. B. Kay. 1991. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens From atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J. Allergy Clin. Immunol. 88:661-674.
5. Beasley, R., W. R. Roche, J. A. Roberts, and S. T. Holgate. 1989. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am. Rev. Respir. Dis. 139:806-817.
6. Kay, A. B., and C. J. Corrigan. 1992. Asthma; cosinophils and neutrophils. Br. Med. Bull. 48:51-64.
7. Luster, A. D. 1998. Chemokines; chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436-445.
8. Luster, A. D., and M. F. Rothenberg, 1997. Role of the monocyte chemoattractaul protein and cotaxin subfamily of ehemokines in allergic inflammation. J. Leukoc. Biol. 62:620-633.
9. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
10. Proost, P., A. Wuyts, and J. Van Damme. 1996. The role of chemokines in inflammation. Int. J. Clin. Lab. Res. 26:211-223.
11. Gu, L., B. Rutledge, J. Fiorillo, C. Ernst, I. Grewal, R. Flavell, R. Gladue, and B. Rollins. 1997. In vivo properties of monocyte chemoattractant protein-1. J. Leukoc. Biol. 62:577-580.
12. Ponath, P. D., S. Qin, T. W. Post, J. Wang, L. Wu, N. P. Gerard, W. Newman, C. Gerard, and C. R. Mackay. 1996. Molecular cloning and charaeterzation of a human cotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183:2437-2448,
13. Garcia-Zepeda, E. A., M. F. Rothenberg, R. T. Ownbey, J. Celestin, P. Leder, and A. D. Luster. 1996. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 2:449-456.
14. Humbert, M., S. Ying, C. Corrigan, G. Menz, J. Barkans, R. Pfister, O. Meng, J. Van Damme, G. Opdenakker, S. R. Durham, and A. B. Kay. 1997. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (II.)-5, granulocyte macrophage-colony-stimulating factor, and IL-3. Am. J. Respir. Cell Mol. Biol. 16:1-8.
15. Sousa, A. R., S. J. Lane, J. A. Nakhosteen, T. Yoshimura, T. H. Lee, and R. N. Poston. 1994. Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 10:142-147.
16. Powell, N., M. Humbert, S. R. Durham, B. Assoufi, A. B. Kay, and C. J. Corrigan. 1996. Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma. Eur. Respir. J. 9:2454-2460.
17. Alam, R., J. York, M. Boyars, S. Stafford, J. A. Grant, J. Lee, P. Forsythe, T. Sim, and N. Ida. 1996. Increased MCT-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Am. J. Respir. Crit. Care Med. 153:1398-1404.
18. Lamkhioued, B., P. M. Renzi, S. Abi-Younes, F. A. Garcia-Zepada, Z. Allakhverdi, O. Ghaffar, M. D. Rothenherg, A. D. Luster, and O. Hamid. 1997. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J. Immunol. 159:4593-4601.
19. Minshall, E. M., L. Cameron, F. Lavigne, D. Y. Leung, O. Hamilos, E. A. Garcia-Zepada, M. Rothenberg, A. D. Luster, and O. Hamid. 1997. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am. J. Respir. Cell Mol. Biol. 17:683-690,
20. Ying, S., L. Taborda-Barata, Q. Meng, M. Humbert, and A. B. Kay. 1995. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in thu skin of human atopic subjects; relationship to eosinophil, T cell, and macrophage recruitment. J. Exp. Med. 181:2153-2159.
21. Lee, T. H., and A. R. Sousa, 1994. Immunoinflammatory role of the airway epithelial cell in asthma. Eur. Respir. Rev. 4:368-370.
22. Saunders, M. A., J. A. Mitchell, P. M. Seldon, M. H. Yacoub, P. J. Barnes, M. A. Giembycz, and M. G. Belvisi. 1997. Release of GM-CSF by human cultured airway smooth muscle cells: suppression by dexamethasone. Br. J. Pharmacol. 120:545-546.
23. John, M., B. T. Au, P. J. Jose, S. Lim, M. Saunders, P. J. Barnes, J. A. Mitchell, M. G. Belvisi, and K. F. Chung. 1998. Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. Am. J. Respir. Cell Mol. Biol. 18:84-90.
24. John, M., S. J. Hirst, P. J. Jose, A. Robichaud, N. Berkman, C. Witt, C. H. Twort, P. J. Barnes, and K. F. Chung. 1997. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J. Immunol. 158: 1841-1847.
25. Hall, I. P., S. Widdop, P. Townsend, and K. Daykin. 1992, Control of cyclic AMP levels in primary cultures of human tracheal smooth muscle cells. Br. J. Pharmacol. 107:422-428.
26. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem 162:156-159.
27. Proost, P., P. Van Leuven, A. Wuyts, R. Ebberink, G. Opdenakker, and J. Van Damme. 1995. Chemical synthesis, purification and folding of the human monocyte chemotactic proteins MCP-2 and MCP-3 into biologically active chemokines. Cytokine 7:97-104.
28. Berkman, N., A. Robichaud, V. L. Krishman, G. Roesems, R. Robbins, P. J. Jose, P. J. Barnes, and K. F. Chung. 1996. Expression of RANTES in human airway epithelial cells: effect of corticosteroids and interleukin-4, -10 and -13. Immunology 87:599-601
29. Berkman, N., A. Robiehaud, R. A. Robbins, G. Roesems, E. B. Haddad, P. J. Barnes, and K. F. Chung. 1996. Inhibition of inducible nitric oxide synthase expression hy interleukin-4 and interleukin-13 in human lung epithelial cells. Immunology 89:363-367.
30. Broide, D. H., M. Lotz, A. J. Cuomo, D. A. Coburn, F. C. Federman, and S. I. Wasserman. 1992. Cytokines in symptomatic asthmatic airways. J. Allergy Clin. Immunol. 89:958-967.
31. Marini, M., F. Avoni, J. Hollemhorg, and S. Mattoli. 1992. Cytokine mRNA profile and cell activation in bronchoalveolar lavage fluid from nonatopic patients with symptomatic asthma. Chest 102:661-669.
32. Krishnaswamy, G., M. C. Liu, S. N. Su, M. Kumai, H. O. Xiao, D. G. Marsh, and S. K. Huang. 1993. Analysis of cytokine transcripts in the bronchoalveolar lavage cells of patients with asthma. Am. J. Respir. Cell Mol. Biol. 9:279-286.
33. While, A. M., T. Yoshimura, A. W. Smith, J. Westwick, and M. I., Watson. 1997. Airway inflammation induced by recombinant guinea pig tumor necrosis factor-alpha. Am. J. Physiol. 273:L524-L530.
34. Thomas, P. S., D. H. Yales, and P. J. Barnes. 1995. Tumor necrosis factor-α increases airway responsiveness and sputum neutrophilia in normal human subjects. Am. J. Respir. Cell Mol. Biol. 152:76-80.
35. Hernandez, A., C. Omini, and L. Daffonchio. 1991. Interleukin-1 beta: a possible mediator of lung inflammation and airway hyperreactivity. Pharmacol. Res. 24:385-393.
36. Watson, M. L., D. Smith, A. D. Bourne, R. C. Thompson, and J. Westwick. 1993. Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: inhibition of airway hyperreactivity, pulmonary eosinophil accumulation, and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist. Ant. J. Respir. Cell Mol. Biol. 8:365-369.
37. Mueller, R., P. Chanez, A. M. Camphell, J. Bousquet, C. Heusser, and G. R. Bullock. 1996. Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis. Respir. Med. 90:79-85.
38. Lilly, C. M., H. Nakamura, H. Kesselman, C. Nagler-Anderson, K. Asano, F. A. Garda-Zepeda, M. F. Rothenberg, J. M. Drazen, and A. D. Luster. 1997. Expression of eotaxin by human lung epithelial colls: induction by cytokines and inhibition by glucocurticoids. J. Clin. Invest. 99:1767-1773.
39. Van Damme, J., P. Proost, W. Put, S. Arens, J. Lenaerts, R. Conings, G. Opdenakker, H. Heremans, and A. Billiau. 1994. Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. J. Immunol. 152:5495-5502.
40. Struyf, S., E. Van Collic, L. Paemen, W. Put, J. P. Lenaerts, P. Proost, G. Opdenakker, and J. Van Damme. 1998. Synergistic induction of MCP-1 and -2 by IL-1beta and interferons in fibroblasts and epithelial cells. J. Leukoc. Biol. 63:364-372.
41. Rollins, B. J., P. Stier, T. Ernst, and G. G. Wong. 1989. The human homolog of the JE gene encodes a monocyte secretory protein. Mol. Cell Biol. 9: 4687-4695.
42. Shyy, Y. J., Y. S. Li, and P. F. Kolattukudy. 1990. Structure of human monocyte chemotactic protein gene and its regulation by TPA. Biochem. Biophys. Res. Commun. 169:346-351.
43. Murakami, K., H. Nomiyama, R. Miura, A. Follens, P. Fiten, E. Van Coillie, J. Van Damme, and G. Opdenakker. 1997. Structural and functional analysis of the promoter region of the human MCP-3 gene: transactivation of expression by novel recognition sequences adjacent to the transcription initiation site. DNA Cell Biol. 16:173-183.
44. Barnes, P. J. 1995. Inhaled glucocorticoids for asthma. N. Engl. J. Med. 332: 868-875.
45. Barnes, P. J., and I. Adcock. 1993. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol. Sci. 14:436-441.
46. Hart, P. H., G. F. Vitti, D. R. Burgess, G. A. Whitty, D. S. Piccoli, and J. A. Hamilton. 1989. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and ptostaglandin E2. Proc. Natl. Acad. Sci. USA 86:3803-3807.
47. Lalani, I., K. Bhol, and A. R. Ahmed. 1997. Interleukin-10; biology, role in inflammation and autoimmunity. Ann. Allergy Asthma Immunol. 79:469-483.
48. Minty, A., P. Chalon, J. M. Derocq, X. Dumont, J. C. Guillemot, M. Kaghad, T. Labit, P. Leplatois, P. Liauzun, and B. Miloux. 1993. Interleukin-13 is a new human lymphokinc regulating inflammatory and immune responses. Nature 362:248-250.
49. de Waal Mulefyt, R., C. G. Figdor, R. Huijbens, S. Mohan-Peterson, B. Bennett, J. Culpepper, W. Dang, G. Zurawski, and J. E. de Vries. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J. Immunol. 151:6370-6381.
50. Standiford, T. J., S. L. Kunkel, J. M. Liebler, M. D. Burdick, A. R. Gilbert, and R. M. Strieter. 1993. Gene expression of macrophage inflammatory protein-1 alpha from human blood monocytes and alveolar macrophages is inhibited by interleukin-4. Am. J. Respir. Cell Mol. Biol. 9:192-198.
51. de Waul Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits eytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209-1220.
52. Lentsch, A. B., T. P. Shanley, V. Sarma, and P. A. Ward, 1997. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. J. Clin. Invest. 100:2443-2448.
53. Barnes, P. J., and I. M. Adcock. 1997. NF-kappa B: a pivotal role in asthma and a new target for therapy. Trend Pharmacol. Sci. 18:46-50.
54. Zund, G., J. L. Madara, A. L. Dzus, T. S. Awtrey, and S. P. Colgan. 1996. Interleukin-4 and interleukin-13 difierentially regulate epithelial chloride secretion. J. Biol. Chem. 271:7460-7464.
55. Cunha, F. Q., S. Poole, B. B. Lorenzetti, F. H. Veiga, and S. H. Ferreira. 1999. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4. Br. J. Pharmacol. 126:45-50.
56. Rollins, B. J., and J. S. Pober. 1991. Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. Am. J. Pathol. 138:1315-1319.
57. Ebina, M., T. Takahashi, T. Chiba, and M. Motomiya. 1993. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am. Rev. Respir. Dis. 148:720-726.
58. Knox, A. J. 1994. Airway re-modelling in asthma: role of airway smooth muscle. Clin. Sci. (Cotch.) 86:647-652.
59. Johnson, S. R., and A. J. Knox. 1997. Synthetic functions of airway smooth muscle in asthma. Trends Pharmacol. Sci. 18:288-292.
60. Hirst, S. J. 1996. Airway smooth muscle cell culture: application to studies of airway wall remodelling and phenotype plasticity in asthma. Eur. Respir. J. 9:808-820.